marcellomycin has been researched along with aclarubicin in 14 studies
| Studies (marcellomycin) | Trials (marcellomycin) | Recent Studies (post-2010) (marcellomycin) | Studies (aclarubicin) | Trials (aclarubicin) | Recent Studies (post-2010) (aclarubicin) |
|---|---|---|---|---|---|
| 31 | 0 | 0 | 826 | 97 | 105 |
| Protein | Taxonomy | marcellomycin (IC50) | aclarubicin (IC50) |
|---|---|---|---|
| 72 kDa type IV collagenase | Homo sapiens (human) | 9.9 | |
| 5-hydroxytryptamine receptor 2B | Homo sapiens (human) | 1.106 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (85.71) | 18.7374 |
| 1990's | 2 (14.29) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Crooke, ST; DuVernay, VH; Pachter, JA | 1 |
| Dahle, M; Marquardt, H; Radenz, G; Schaefer, A; Steinheider, G | 1 |
| Frank, DA; Sartorelli, AC | 1 |
| Takatsuki, A; Tamura, G | 1 |
| Monneret, C; Sellier, N | 1 |
| Marquardt, H; Steinheider, G; Westendorf, J | 1 |
| Bachur, NR; Dodion, P; Egorin, MJ; Ferraro, TA; Riggs, CE; Tamburini, JM | 1 |
| Crooke, ST; DuVernay, VH; Mong, S; Strong, JE | 1 |
| Morin, MJ; Sartorelli, AC | 1 |
| Ketkar, MB; Marquardt, H; Mohr, U; Westendorf, J | 1 |
| Brown, BJ; Marsh, JC; Nierenburg, M; Sartorelli, AC; Schwartz, EL | 1 |
| Brown, BJ; Marsh, JC; Nierenburg, MM | 1 |
| Crooke, ST; Loth, H; Seeber, S | 1 |
| Nitiss, JL; Pommier, Y; Pourquier, P | 1 |
1 review(s) available for marcellomycin and aclarubicin
| Article | Year |
|---|---|
[Inhibitors affecting synthesis and intracellular translocation of glycoproteins as probes].
Topics: 1-Deoxynojirimycin; Aclarubicin; Animals; Anthracyclines; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Bacitracin; Biological Transport; Glucosamine; Glycoproteins; Lipopeptides; Lysosomes; Monensin; Naphthacenes; Oligopeptides; Showdomycin; Tunicamycin | 1985 |
13 other study(ies) available for marcellomycin and aclarubicin
| Article | Year |
|---|---|
Deoxyribonucleic acid binding studies on several new anthracycline antitumor antibiotics. Sequence preference and structure--activity relationships of marcellomycin and its analogues as compared to adriamycin.
Topics: Aclarubicin; Animals; Anthracyclines; Antibiotics, Antineoplastic; Base Sequence; Cattle; Chemical Phenomena; Chemistry; DNA; DNA, Bacterial; Doxorubicin; Kinetics; Naphthacenes; Polydeoxyribonucleotides; Salmon; Spectrometry, Fluorescence; Structure-Activity Relationship; Thymus Gland | 1979 |
Structure-activity relationship between anthracycline-induced differentiation and inhibition of glycoprotein synthesis in Friend erythroleukemia cells.
Topics: Aclarubicin; Animals; Anthracyclines; Antibiotics, Antineoplastic; Cell Differentiation; Cell Line; Cell Survival; Daunorubicin; Dose-Response Relationship, Drug; Doxorubicin; Friend murine leukemia virus; Glycoproteins; Hemoglobins; Leukemia, Erythroblastic, Acute; Mannose; Mice; Tunicamycin | 1991 |
Alterations in tyrosine phosphorylation during the granulocytic maturation of HL-60 leukemia cells.
Topics: Aclarubicin; Anthracyclines; Antibiotics, Antineoplastic; Cell Differentiation; Dimethyl Sulfoxide; Humans; Leukemia, Myeloid, Acute; Naphthacenes; Phosphoprotein Phosphatases; Phosphorylation; Protein Tyrosine Phosphatases; Protein-Tyrosine Kinases; Thioguanine; Tumor Cells, Cultured; Tyrosine | 1988 |
Desorption chemical ionization mass spectrometry of anthracyclines and of trisaccharides related to aclacinomycin A and marcellomycin.
Topics: Aclarubicin; Anthracyclines; Antibiotics, Antineoplastic; Chemical Phenomena; Chemistry; Disaccharides; Mass Spectrometry; Naphthacenes; Trisaccharides | 1986 |
Induction of erythroid differentiation by the anthracycline antitumor antibiotics, aclacinomycin A, musettamycin and marcellomycin.
Topics: Aclarubicin; Animals; Anthracyclines; Antibiotics, Antineoplastic; Cell Differentiation; Cell Line; Friend murine leukemia virus; Humans; Leukemia, Erythroblastic, Acute; Mice; Naphthacenes; Rats; Structure-Activity Relationship | 1986 |
Comparative murine metabolism and disposition of class II anthracycline antibiotics.
Topics: Aclarubicin; Animals; Anthracyclines; Antibiotics, Antineoplastic; Chromatography, High Pressure Liquid; Computers; Male; Mice; Naphthacenes; Spectrometry, Fluorescence; Tissue Distribution | 1985 |
Interaction of anthracyclines with covalently closed circular DNA.
Topics: Aclarubicin; Anthracyclines; Antibiotics, Antineoplastic; Bleomycin; Carubicin; Centrifugation, Density Gradient; Daunorubicin; Diffusion; DNA, Circular; Doxorubicin; Drug Interactions; Electrophoresis, Agar Gel; Molecular Conformation; Naphthacenes | 1980 |
Inhibition of glycoprotein biosynthesis by the inducers of HL-60 cell differentiation, aclacinomycin A and marcellomycin.
Topics: Aclarubicin; Anthracyclines; Antibiotics, Antineoplastic; Cell Differentiation; Cell Division; Cell Line; Glycoproteins; Humans; Kinetics; Leukemia, Myeloid, Acute; Naphthacenes; Oligosaccharides; Receptors, Cell Surface; Receptors, Transferrin; Transferrin | 1984 |
Tumorigenicity in vivo and induction of mutagenesis and DNA repair in vitro by aclacinomycin A and marcellomycin: structure-activity relationship and predictive value of short-term tests.
Topics: Aclarubicin; Animals; Anthracyclines; Anti-Bacterial Agents; Antibiotics, Antineoplastic; Carcinogens; Cell Line; Cricetinae; Cricetulus; DNA Repair; Drug Evaluation, Preclinical; Lung; Male; Microsomes, Liver; Mutagenicity Tests; Mutagens; Mutation; Naphthacenes; Neoplasms, Experimental; Rats; Rats, Inbred Strains; Salmonella typhimurium | 1983 |
Evaluation of some anthracycline antibiotics in an in vivo model for studying drug-induced human leukemia cell differentiation.
Topics: Aclarubicin; Animals; Anthracyclines; Antibiotics, Antineoplastic; Cell Differentiation; Cell Division; Female; Humans; Leukemia, Myeloid, Acute; Mice; Models, Biological; Naphthacenes | 1983 |
Sensitivity of bone marrow hematopoietic colony-forming cells from mice, dogs, and humans to carminomycin, marcellomycin, aclacinomycin A, and N,N-dibenzyldaunorubicin and its relationship to clinical toxicity.
Topics: Aclarubicin; Animals; Anthracyclines; Antibiotics, Antineoplastic; Carubicin; Daunorubicin; Dogs; Dose-Response Relationship, Drug; Female; Hematopoietic Stem Cells; Male; Mice; Naphthacenes; Species Specificity | 1983 |
Comparative nuclear and cellular incorporation of daunorubicin, doxorubicin, carminomycin, marcellomycin, aclacinomycin A and AD 32 in daunorubicin-sensitive and -resistant Ehrlich ascites in vitro.
Topics: Aclarubicin; Animals; Anthracyclines; Antibiotics, Antineoplastic; Carcinoma, Ehrlich Tumor; Carubicin; Cell Nucleus; Daunorubicin; DNA, Neoplasm; Doxorubicin; Drug Resistance; Female; In Vitro Techniques; Mice; Naphthacenes | 1980 |
Aclacinomycin A stabilizes topoisomerase I covalent complexes.
Topics: Aclarubicin; Anthracyclines; Antibiotics, Antineoplastic; Base Sequence; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Genotype; Humans; Kinetics; Oligodeoxyribonucleotides; Saccharomyces cerevisiae; Substrate Specificity | 1997 |